You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Proteinase-3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency Trial in Worldwide (Alpha-1 MP)

Enrolling by invitation
  • Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
  • Alpha-1 MP
  • Phoenix, Arizona
  • +24 more
Dec 7, 2022

Evaluation of Anti-neutrophil Cytoplasm Antibodies Test

Not yet recruiting
  • Immunological Testing in Small-vessel Vasculitis
  • Indirect immunofluorescence (IIF) , myeloperoxidase antibody(MPO)- and anti-proteinase 3 (PR3-) ANCA immunoassays
  • Miki, Kagawa, Japan
    Kagawa univeristy
Jan 19, 2021

COPD, Alpha1-antitrypsin Deficiency Trial in Australia, Canada, United States (ARALAST NP 60 mg/kg, ARALAST NP 120 mg/kg,

Terminated
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Alpha1-antitrypsin Deficiency
  • ARALAST NP 60 mg/kg
  • +4 more
  • Peoria, Arizona
  • +16 more
Apr 17, 2021

Pulmonary Emphysema in Alpha-1 PI Deficiency Trial in Worldwide (Alpha-1 MP, 0.9% Sodium Chloride for Injection, USP)

Recruiting
  • Pulmonary Emphysema in Alpha-1 PI Deficiency
  • Alpha-1 MP
  • 0.9% Sodium Chloride for Injection, USP
  • Phoenix, Arizona
  • +50 more
Dec 7, 2022

Alpha1-antitrypsin Deficiency Trial in Canada, United States (GLASSIA)

Completed
Has Results
  • Alpha1-antitrypsin Deficiency
  • GLASSIA
  • Tucson, Arizona
  • +17 more
Sep 17, 2021

Acute-graft-versus-host Disease Trial in Worldwide (Alpha-1 antitrypsin (AAT), Placebo)

Recruiting
  • Acute-graft-versus-host Disease
  • Alpha-1 antitrypsin (AAT)
  • Placebo
  • Scottsdale, Arizona
  • +19 more
Sep 8, 2022

GVHD Trial in Augusta (GLASSIA, methylprednisolone or equivalent steroid, Albumin)

Terminated
Has Results
  • Graft Versus Host Disease
  • GLASSIA
  • +2 more
  • Augusta, Georgia
    Georgia Cancer Center
Dec 22, 2020

Granulomatosis With Polyangiitis, Microscopic Polyangiitis, ANCA Associated Vasculitis Trial in Boston, Rochester, Philadelphia

Not yet recruiting
  • Granulomatosis With Polyangiitis
  • +2 more
  • Boston, Massachusetts
  • +2 more
Dec 29, 2022

HIV Disease Trial in New York (alpha-1-Proteinase Inhibitor)

Completed
Has Results
  • HIV Disease
  • alpha-1-Proteinase Inhibitor
  • New York, New York
    Cabrini Medical Center
Aug 31, 2021

Bronchiectasis Adult Trial in Dundee (Alpha 1-Proteinase Inhibitor 180mg/kg, Alpha 1-Proteinase Inhibitor 120mg/kg, Sodium

Not yet recruiting
  • Bronchiectasis Adult
  • Alpha 1-Proteinase Inhibitor 180mg/kg
  • +2 more
  • Dundee, United Kingdom
    NHS Tayside
Oct 12, 2022

Alpha1-Antitrypsin Deficiency Trial in Aomori, Hokkaido, Tokyo (Alpha-1 MP)

Completed
Has Results
  • Alpha1-Antitrypsin Deficiency
  • Alpha-1 MP
  • Aomori, Japan
  • +2 more
Mar 22, 2022

Myeloid Leukemia, Chronic Trial in Berlin, Bremen (DC vaccine)

Recruiting
  • Myeloid Leukemia, Chronic
  • DC vaccine
  • Berlin, Germany
  • +1 more
Aug 3, 2021

Healthy Volunteers Trial in Glendale (INS1007, Placebo)

Completed
  • Healthy Volunteers
  • Glendale, California
    USA001
Jun 22, 2023

Alpha 1-Antitrypsin Deficiency Trial in Australia, New Zealand (Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor, Dose

Completed
Has Results
  • Alpha 1-Antitrypsin Deficiency
  • Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor
  • Dose of 60 mg/kg alpha1-proteinase inhibitor
  • Adelaide, South Australia, Australia
  • +6 more
Apr 17, 2021

Alpha1-Antitrypsin Deficiency Trial in Sapporo, Tokyo (Alpha-1 MP)

Completed
Has Results
  • Alpha1-Antitrypsin Deficiency
  • Alpha-1 MP
  • Sapporo, Japan
  • +1 more
Oct 13, 2021

ANCA Associated Vasculitis, Granulomatosis With Polyangiitis Trial in United Kingdom (Belimumab, Rituximab, Prednisolone)

Active, not recruiting
  • ANCA Associated Vasculitis
  • Granulomatosis With Polyangiitis
  • Cambridge, United Kingdom
  • +5 more
Feb 21, 2022

Alpha 1-Antitrypsin Deficiency, Emphysema Trial in Australia, United States (INBRX-101, Zemaira)

Recruiting
  • Alpha 1-Antitrypsin Deficiency
  • Emphysema
  • Birmingham, Alabama
  • +25 more
May 11, 2023

Alpha 1-Antitrypsin Deficiency Trial in Australia, New Zealand (Alpha1-Proteinase Inhibitor)

Completed
Has Results
  • Alpha 1-Antitrypsin Deficiency
  • Alpha1-Proteinase Inhibitor
  • Adelaide, South Australia, Australia
  • +4 more
Apr 17, 2021

Healthy Subject Trial in Beijing, Xingtai (STSA-1002 Injection, Placebo)

Not yet recruiting
  • Healthy Subject
  • STSA-1002 Injection
  • Placebo
  • Beijing, Beijing, China
  • +1 more
Aug 9, 2022

Urine Alkalinazation on Urinary Inflammatory Markers in

Completed
  • Cystinuria
  • +3 more
  • Potassium citrate
  • Paris, Ile-de-France, France
    Eurpean Georges Pompidou Hospital
Mar 21, 2022

Vasculitis Trial in Netherlands (azathioprine)

Terminated
  • Vasculitis
  • Amsterdam, Netherlands
  • +7 more
Dec 11, 2018

HIV Disease Trial in New York (a1 Proteinase Inhibitor, Placebos)

Terminated
Has Results
  • HIV Disease
  • α1 Proteinase Inhibitor
  • Placebos
  • New York, New York
    ACRIA
Aug 22, 2020

Alpha1-antitrypsin Deficiency Trial in San Marino (ARALAST Alpha1-Proteinase Inhibitor)

Terminated
Has Results
  • Alpha1-antitrypsin Deficiency
  • ARALAST Alpha1-Proteinase Inhibitor
  • San Marino, California
    Adupa Rao, MD
May 3, 2021

Anesthesia Trial in Damanhur (Propofol, Sevoflurane)

Recruiting
  • Anesthesia
  • Damanhūr, Elbehairah, Egypt
    Damanhour Teaching Hospital, General Organization for Teaching H
Oct 14, 2022

Leukemia Trial in Houston (Peptide Vaccine (PR1 Peptide), Peginterferon alfa-2b, Imatinib)

Terminated
Has Results
  • Leukemia
  • Peptide Vaccine (PR1 Peptide)
  • +3 more
  • Houston, Texas
    UT MD . Anderson Cancer Center
Jul 23, 2018